UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Kontoor Brands
KTB
$4.26B
| $1.03M | ﹤0.01% |
57,556
-4,781
| -8% | -$85.2K |
|
1752
NBT Bancorp
NBTB
$2.74B
| $1.02M | ﹤0.01% |
33,127
-17,295
| -34% | -$539K |
|
1753
Laureate Education
LAUR
$5.28B
| $1.02M | ﹤0.01% |
102,054
-38,057
| -27% | -$368K |
|
|
GOOS
1754
Canada Goose Holdings
GOOS
$856M
| $1.02M | ﹤0.01% |
43,897
+8,500
| +24% | +$189K |
|
1755
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.01M | ﹤0.01% |
42,630
+11,643
| +38% | +$257K |
|
1756
Radware
RDWR
$1.19B
| $1.01M | ﹤0.01% |
42,918
+7,400
| +21% | +$170K |
|
1757
Mesa Laboratories
MLAB
$574M
| $1.01M | ﹤0.01% |
4,667
+1,482
| +47% | +$342K |
|
1758
Telecom Argentina
TEO
$5.96B
| $1.01M | ﹤0.01% |
112,785
-20,204
| -15% | -$168K |
|
|
MYOV
1759
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.01M | ﹤0.01% |
48,949
+23,106
| +89% | +$314K |
|
1760
Employers Holdings
EIG
$889M
| $1.01M | ﹤0.01% |
33,466
-4,222
| -11% | -$130K |
|
1761
TTM Technologies
TTMI
$14.5B
| $1.01M | ﹤0.01% |
84,844
-3,829
| -4% | -$42.6K |
|
1762
Alamo Group
ALG
$2.05B
| $1M | ﹤0.01% |
9,790
+2,301
| +31% | +$221K |
|
|
REGI
1763
DELISTED
Renewable Energy Group, Inc.
REGI
| $1M | ﹤0.01% |
40,535
-283
| -0.7% | -$7.17K |
|
|
BBBY
1764
Bed Bath & Beyond
BBBY
$442M
| $1M | ﹤0.01% |
38,853
+25,741
| +196% | +$378K |
|
|
CATM
1765
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $1M | ﹤0.01% |
41,744
-1,624
| -4% | -$36.4K |
|
1766
Carpenter Technology
CRS
$28.4B
| $1,000K | ﹤0.01% |
41,178
-7,469
| -15% | -$166K |
|
|
RVNC
1767
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1,000K | ﹤0.01% |
40,935
+5,871
| +17% | +$116K |
|
1768
Hyatt Hotels
H
$16.7B
| $997K | ﹤0.01% |
19,818
-4,903
| -20% | -$261K |
|
1769
Abercrombie & Fitch
ANF
$5B
| $995K | ﹤0.01% |
93,536
+8,584
| +10% | +$93.7K |
|
1770
OSI Systems
OSIS
$3.89B
| $995K | ﹤0.01% |
13,325
-738
| -5% | -$53.9K |
|
|
INFN
1771
DELISTED
Infinera Corporation Common Stock
INFN
| $994K | ﹤0.01% |
167,945
+3,602
| +2% | +$19.7K |
|
|
GCP
1772
DELISTED
GCP Applied Technologies Inc.
GCP
| $994K | ﹤0.01% |
53,472
-9,833
| -16% | -$177K |
|
|
HTLF
1773
DELISTED
Heartland Financial USA, Inc.
HTLF
| $990K | ﹤0.01% |
29,620
-2,243
| -7% | -$70.1K |
|
1774
Regenxbio
RGNX
$708M
| $990K | ﹤0.01% |
26,890
+4,525
| +20% | +$169K |
|
|
CSII
1775
DELISTED
Cardiovascular Systems, Inc.
CSII
| $989K | ﹤0.01% |
31,343
-5,424
| -15% | -$203K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.